Monica Guzman, Ph.D., is an Associate Professor of Pharmacology in Medicine, appointed in the Division of Hematology & Medical Oncology in the Department of Medicine. She was recruited to Weill Cornell Medical College in 2009 from the University of Rochester.

As the first scientist to identify dysregulated gene networks in leukemia stem cells and capitalize on this dysregulation to develop therapies to destroy them, Dr. Guzman is widely viewed as one of the world’s foremost experts in therapeutic targeting of leukemia stem cells. She has authored or co-authored numerous papers in the field and has received funding from the NIH, Leukemia & Lymphoma Society, V Foundation, and other organizations.

Dr. Guzman’s passion is to perform world-class translational research through close interactions between research and clinic to accelerate the development of new and more effective leukemia treatments that ablate leukemia stem cells.